Cargando…

Targeting B Cells and Plasma Cells in Autoimmune Diseases

Success with B cell depletion using rituximab has proven the concept that B lineage cells represent a valid target for the treatment of autoimmune diseases, and has promoted the development of other B cell targeting agents. Present data confirm that B cell depletion is beneficial in various autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofmann, Katharina, Clauder, Ann-Katrin, Manz, Rudolf Armin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924791/ https://www.ncbi.nlm.nih.gov/pubmed/29740441 http://dx.doi.org/10.3389/fimmu.2018.00835

Ejemplares similares

Bone Marrow Plasma Cells Modulate Local Myeloid-Lineage Differentiation via IL-10
por: Meng, Lingzhang, et al.
Publicado: (2019)

IL-2-Agonist-Induced IFN-γ Exacerbates Systemic Anaphylaxis in Food Allergen-Sensitized Mice
por: Link, Christopher W.M., et al.
Publicado: (2020)

Editorial: Next generation B cell targeting therapies in autoimmune diseases
por: Li, Rui, et al.
Publicado: (2023)

Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy
por: Mahévas, Matthieu, et al.
Publicado: (2013)

B cell targeted therapies in inflammatory autoimmune disease of the central nervous system
por: Furman, Moritz J., et al.
Publicado: (2023)

A Novel Role for C5a in B-1 Cell Homeostasis
por: Bröker, Katharina, et al.
Publicado: (2018)

Self-Antigen Presentation by Dendritic Cells in Autoimmunity
por: Hopp, Ann-Katrin, et al.
Publicado: (2014)

Advances of Regulatory B Cells in Autoimmune Diseases
por: Zhu, Qiugang, et al.
Publicado: (2021)

B Cell Dysfunction Associated With Aging and Autoimmune Diseases
por: Ma, Shiliang, et al.
Publicado: (2019)

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
por: Raker, Verena Katharina, et al.
Publicado: (2016)

Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases
por: Municio, Cristina, et al.
Publicado: (2021)

Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target
por: Li, Zhen-yu, et al.
Publicado: (2023)

B Cell Modulation Strategies in Autoimmune Diseases: New Concepts
por: Musette, Philippe, et al.
Publicado: (2018)

Application of single-cell RNA sequencing methods to develop B cell targeted treatments for autoimmunity
por: Nicholas, Catherine A., et al.
Publicado: (2023)

B cell metabolism in autoimmune diseases: signaling pathways and interventions
por: Li, Jingyue, et al.
Publicado: (2023)

B Cell Metabolism and Autophagy in Autoimmunity
por: Raza, Iwan G. A., et al.
Publicado: (2021)

IL-10 revisited in systemic lupus erythematosus
por: Biswas, Swayanka, et al.
Publicado: (2022)

Influence of nutrients and metabolites on the differentiation of plasma cells and implications for autoimmunity
por: Föh, Bandik, et al.
Publicado: (2022)

Targeted Expression of Myelin Autoantigen in the Periphery Induces Antigen-Specific T and B Cell Tolerance and Ameliorates Autoimmune Disease
por: Na, Shin-Young, et al.
Publicado: (2021)

T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship
por: Petersone, Lina, et al.
Publicado: (2018)

Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases
por: Lee, Jae-Ung, et al.
Publicado: (2018)

Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
por: Gianchecchi, Elena, et al.
Publicado: (2021)

Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
por: Weißenberg, Sarah Y., et al.
Publicado: (2019)

Targeting Plasma Cells in Autoimmune Diseases
por: Tarlinton, David M., et al.
Publicado: (2004)

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
por: Park, Byunghyun, et al.
Publicado: (2023)

Dissecting Integrin Expression and Function on Memory B Cells in Mice and Humans in Autoimmunity
por: Camponeschi, Alessandro, et al.
Publicado: (2019)

Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases
por: Chávez, Miranda D., et al.
Publicado: (2021)

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
por: Fiorina, Paolo, et al.
Publicado: (2008)

Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease
por: Sciascia, Savino, et al.
Publicado: (2022)

Upregulated Fcrl5 disrupts B cell anergy causes autoimmune disease
por: Ono, Chisato, et al.
Publicado: (2023)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

The Role of Latently Infected B Cells in CNS Autoimmunity
por: Márquez, Ana Citlali, et al.
Publicado: (2015)

Antidepressants cheer up hepatic B1 B cells: Hope for the treatment of autoimmune liver diseases?
por: Amendt, Timm, et al.
Publicado: (2023)

NK Cell Autoreactivity and Autoimmune Diseases
por: Poggi, Alessandro, et al.
Publicado: (2014)

T Cells in Autoimmunity-Associated Cardiovascular Diseases
por: Schwartz, Daniella Muallem, et al.
Publicado: (2020)

Innate Lymphoid Cells in Autoimmune Diseases
por: Clottu, Aurelie S., et al.
Publicado: (2022)

Short-lived Plasmablasts and Long-lived Plasma Cells Contribute to Chronic Humoral Autoimmunity in NZB/W Mice
por: Hoyer, Bimba F., et al.
Publicado: (2004)

Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease
por: Yuksel, Muhammed, et al.
Publicado: (2023)

Dietary Supplementation With Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity
por: Kobayashi, Azusa, et al.
Publicado: (2021)

Cytokine Targeting by miRNAs in Autoimmune Diseases
por: Salvi, Valentina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_23hmikhc26upip3a4udmmdd1gv